$5 million in seed investment was obtained by the Pasadena, California-based stroke detection technology startup StrokeDx.
Investors
- DigiTx Partners
- Freeflow Ventures
- current investors with notable achievements in the fields of medical devices, stroke, and neuroradiology.
- DigiTx Partners’ Managing Director, David J. Kim, MD, will be joining the board.
Use of funds
The money will be used by the firm to expand its commercial endeavors and conduct more clinical validation of its technology.
Nearly $10 million has been collected thus far for StrokeDx’s technology, including a R01 grant from the National Institutes of Health (NIH).
About StrokeDx
StrokeDx, under the direction of CEO Alexander Ballatori, is a leader in creating cutting-edge hardware and software for portable, non-invasive, non-radiating cerebrovascular monitoring. Utilizing cutting-edge technology created by Shane Shahrestani, MD, PhD, at the California Institute of Technology (Caltech), the company’s creative approach provides an accurate way to assess strokes. Caltech is at the forefront of creating stroke detection technology.
